The brake on neurodegeneration
Increased mitochondrial metabolism in the injured MS spinal cord
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology®, Ciccarelli et al.1 present an intriguing study assessing 14 patients with multiple sclerosis (MS) at the time of an acute relapse related to a lesion at the spinal C1–C3 level. The authors performed magnetic resonance spectroscopy (MRS) and atrophy measurements on spinal cords of these 14 patients with MS and 13 age- and gender-matched healthy controls. Spinal N-acetylaspartate (NAA) concentrations were calculated at baseline and followed for 1, 3, and 6 months, as was spinal cord cross-sectional area. The investigators found that after an initial decrease in the first month, NAA levels recovered partially in the months after the inflammatory demyelinating event, and that patients who recovered showed a greater increase in NAA after 1 month. Spinal cord cross-sectional area gradually decreased over time and was independent of NAA recovery and, interestingly, of clinical outcome. The authors report that longer disease duration at baseline predicted less NAA recovery over time, suggesting that repair processes become “burnt-out” (i.e., less effective) with progressing disease.
NAA is abundantly present in the human CNS, especially in neurons, and decreased levels of NAA, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cybrids in Alzheimer's disease: A cellular model of the disease?R. H. Swerdlow, J. K. Parks, D. S. Cassarino et al.Neurology, October 01, 1997 -
Articles
Spinal cord repair in MSDoes mitochondrial metabolism play a role?O. Ciccarelli, D. R. Altmann, M. A. McLean et al.Neurology, January 27, 2010 -
Articles
Oxidative stress and the pathogenesis of Parkinson's diseasePeter Jenner, C. Warren Olanow et al.Neurology, December 01, 1996 -
Articles
Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infectionM. R. Lentz, W. K. Kim, V. Lee et al.Neurology, April 27, 2009